The antihyperglycemic, antiatherosclerotic, and anti-inflammatory properties of adiponectin make it an attractive therapeutic target for the treatment of obesity and insulin resistance. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.